Study on Low Dose Temozolomide Plus Metformin or Placebo in Patient With Recurrent or Refractory Glioblastoma
Clinical trial NCT03243851 · COMPLETED
Trial details
- NCT number
- NCT03243851
- Sponsor
- Yong-Kil Hong
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-21
- Primary completion
- 2020-12-31
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.